UK Markets close in 7 hrs 1 min

Biocept, Inc. (BIOC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.9482+0.0720 (+8.22%)
At close: 04:00PM EDT
0.9725 +0.02 (+2.56%)
After hours: 07:50PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.8762
Open0.8800
Bid0.0000 x 1100
Ask0.0000 x 1100
Day's range0.8516 - 0.9600
52-week range0.8400 - 4.5300
Volume478,064
Avg. volume112,159
Market cap15.97M
Beta (5Y monthly)0.48
PE ratio (TTM)4.33
EPS (TTM)0.2190
Earnings date28 Mar 2022 - 01 Apr 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est9.50
  • Business Wire

    Biocept Appoints RSM as Independent Auditor

    SAN DIEGO, June 27, 2022--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces the appointment of RSM US LLP ("RSM") as its independent registered public accounting firm effective June 24, 2022. RSM was recently ranked the fifth largest accounting, tax and consulting services firm in the U.S. for the 16th straight year by Accounting Today.

  • Business Wire

    Biocept to Hold Business Strategy Conference Call Today

    SAN DIEGO, June 07, 2022--Biocept, Inc. (Nasdaq: BIOC) management will hold a conference call today, June 7, 2022, beginning at 4:00 p.m. Eastern time to discuss its re-focused and rationalized business strategy and to answer questions.

  • Business Wire

    Biocept Reports First Quarter 2022 Financial Results

    SAN DIEGO, May 23, 2022--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results for the three months ended March 31, 2022 and provides a business update.